These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2219309)

  • 21. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.
    Coster DJ; Williams KA
    Am J Ophthalmol; 2005 Dec; 140(6):1112-22. PubMed ID: 16376660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of the OX40 ligand prolongs corneal allograft survival.
    Hattori T; Usui Y; Okunuki Y; Sonoda Y; Usui M; Takada E; Mizuguchi J; Yagita H; Okumura K; Akiba H; Takeuchi M
    Eur J Immunol; 2007 Dec; 37(12):3597-604. PubMed ID: 18022861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organ-specific differences in the pattern of allograft rejection in the mouse.
    Zhang Z; Zhu L; Garcia B; Duff J; Stiller C; Grant D; Zhong R
    Transplant Proc; 1996 Oct; 28(5):2487. PubMed ID: 8907917
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymph node removal enhances corneal graft survival in mice at high risk of rejection.
    Plsková J; Holán V; Filipec M; Forrester JV
    BMC Ophthalmol; 2004 Mar; 4():3. PubMed ID: 15038832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell-mediated immune responses in alloepithelial rejection after murine keratoepithelioplasty.
    Miyazaki D; Inoue Y; Yao YF; Okada AA; Shimomura Y; Hayashi K; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2590-7. PubMed ID: 10509654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of tumor necrosis factor-related apoptosis-inducing ligand in corneal transplantation.
    Xie L; Shi W; Guo P
    Transplantation; 2003 Dec; 76(11):1556-9. PubMed ID: 14702523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conditions affecting enhanced corneal allograft survival by oral immunization.
    Ma D; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1835-46. PubMed ID: 9727406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential chemokine gene expression in corneal transplant rejection.
    Yamagami S; Miyazaki D; Ono SJ; Dana MR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2892-7. PubMed ID: 10549649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. J2 prolongs the corneal allograft survival through inhibition of the CD4+ T cell-mediated response in vivo.
    Xiao H; Zhang H; Yu ZY; Zhang L; Yu M; Huang YF; Li S; Shen BF; Li Y
    Transpl Immunol; 2007 Nov; 18(2):130-7. PubMed ID: 18005857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xenoreactive CD4+ T cells and acute rejection of orthotopic guinea pig corneas in mice.
    Tanaka K; Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1827-32. PubMed ID: 10845605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
    Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-T cell monoclonal antibodies for in vivo treatment of cardiac allograft rejection in mice.
    Mottram PL; Smyth M; Pietersz GA; Clunie GJ; McKenzie IF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1020-1. PubMed ID: 2650063
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of CD4 depleting and nondepleting monoclonal antibodies in the mouse heart allograft model.
    Han WR; Mottram PL; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2933-4. PubMed ID: 8105591
    [No Abstract]   [Full Text] [Related]  

  • 37. CD4 T cells and allograft rejection.
    Hao L; Wang Y; Gill RG; Lafferty KJ
    Transplant Proc; 1988 Feb; 20(1):56-60. PubMed ID: 2449753
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
    Hori J; Joyce NC; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.